ARHGAP40 Activators
ARHGAP40 Activators are a group of chemical compounds that enhance the functional activity of ARHGAP40 through indirect modulation of the RhoA GTPase and related signaling pathways. These activators work on different parts of the RhoA signaling cascade, either by increasing the activity of RhoA itself, which provides more substrate for ARHGAP40 to act upon, or by modulating the actin cytoskeleton and other Rho family GTPases, which requires ARHGAP40 to recalibrate the actin dynamics and Rho GTPase balance within the.. can you complete this paragraoh and add another one cell. By influencing the actin cytoskeleton and Rho family GTPases, ARHGAP40 Activators indirectly enhance ARHGAP40's function in cytoskeletal reorganization. This enhancement leads to a more dynamic actin structure, facilitating various cellular processes such as cell migration, adhesion, and morphological changes. The activators function by altering the equilibrium between the active and inactive forms of RhoA and other GTPases, thus creating a cellular environment that necessitates increased ARHGAP40 activity to maintain cellular homeostasis and signaling fidelity.
In addition to modulating the RhoA GTPase pathway, these activators also impact related signaling networks, including those involving other small GTPases such as Rac1 and Cdc42. By influencing these pathways, ARHGAP40 Activators contribute to the overall regulation of cell polarity and motility. The diversity in the modes of action of these compounds reflects the multifaceted nature of ARHGAP40's role in cellular signaling. Some activators directly increase RhoA GTPase activity, while others work more subtly by modulating upstream or downstream components of the RhoA pathway. Collectively, these ARHGAP40 Activators, through their targeted effects on RhoA signaling and actin cytoskeletal dynamics, facilitate the enhancement of ARHGAP40-mediated functions in the cell, playing a vital role in maintaining the dynamic equilibrium necessary for effective cellular responses to various stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
Thymosin β4 is an actin-sequestering molecule, which in turn can lead to a compensatory increase in actin dynamics. ARHGAP40 is involved in remodeling the actin cytoskeleton through its GAP activity towards RhoA, which regulates actin stress fibers. Enhanced actin dynamics necessitate increased ARHGAP40 activity to maintain cytoskeletal organization. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Lysophosphatidic Acid (LPA) activates RhoA through its G-protein coupled receptors. As ARHGAP40 is a GAP for RhoA, the activation of RhoA by LPA indirectly enhances the activity of ARHGAP40 as it works to inactivate RhoA. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin inhibits the interaction between RhoA and its guanine nucleotide exchange factors (GEFs). ARHGAP40 is a RhoGAP for RhoA, and inhibition of RhoA activation enhances the relative importance of ARHGAP40's inactivation of RhoA. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is an inhibitor of Cdc42, another Rho GTPase family member. Inhibition of Cdc42 can lead to a compensatory increase in ARHGAP40 activity as the cell attempts to maintain a balance among the activities of the Rho family GTPases. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Cell-permeable C3 Transferase inhibits RhoA, B, and C by ADP-ribosylation. This inhibition indirectly increases the functional activity of ARHGAP40 as it may enhance its GAP activity to compensate for the diminished RhoA function. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC23766 inhibits Rac1, another Rho GTPase. This inhibition can lead to enhanced ARHGAP40 activity to adjust the activity levels of the Rho GTPase family within the cell, given its role in inactivating RhoA. | ||||||